Chimerix, Inc.Long
CMRX $2.10 in cash and no debt / enough to sustain through 2026
smart investors / Insiders are buying as well / year end tax loss harvesting is almost done and I believe biotechs will run fast in jan / feb
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.